Delivery Order SPE2DB20D3101-SPE2DB23FQUU1

Award Date 11/14/22
Potential Completion Date 11/15/22
Potential Value $3.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,162.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cefazolin 1 gm vials, a type of antibiotic medication. The contract has an ultimate completion date of December 18, 2023 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $3,140.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,688 vials of Cefazolin 1 GM. The contract is a Delivery Order with a Firm Fixed Price of $5,827.84 and an Ultimate Completion Date of November 3, 2023. The contract is awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, SPE2DB20D3103|SPE2DB24FM6W0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,799.32 firm-fixed-price delivery order is for the supply of 4,563,666,052 vials of Cefazolin 10 GM, a generic antibiotic medication. The contract has an ultimate completion date of February 15, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
The federal contract award SPE2DX15D6028|SPE2DX25FWFTV was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,210.32 firm fixed-price delivery order is for the supply of 4,566,605,401 units of Cefazolin 1GM 24S, a critical antibiotic medication. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,445.28 firm fixed price contract is for the delivery of Cefazolin 2 g/50 ml-dextrose, a critical antibiotic medication, with a performance period through November 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to provide a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,161.82 firm fixed-price delivery order contract is for the supply of Cefazolin 2 g/50 ml-dextroses, a critical medical commodity. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, SPE2DB22D3009|SPE2DB25FAH17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,083.96 firm fixed-price delivery order is for the supply of 4,566,196,865 units of the antibiotic medication Cefazolin 2 g/50 ml-dextrose. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,810.88, is a Firm Fixed Price Delivery Order for the supply of Cefazolin 2g/50ml-Dextroses, a medication used for various medical treatments. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $7,639.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFAZOLIN 2 G/50 ML-DEXTROSE medical supplies, which are critical pharmaceutical products used in military and government healthcare settings. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FQUU1
    Delivery Order

This federal contract award, valued at $3,070.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,092,116 units of Cefazolin 2 GM Vials, a critical antibiotic medication used in medical settings. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 2/27/25, 11:17 AM